Overview

A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)

Status:
Not yet recruiting

Trial end date:
2023-10-09

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the consistency of therapeutic response of gepotidacin at the Test of cure (TOC) Visit (Days 10 to 13) in female participants with acute uncomplicated cystitis with qualifying bacterial uropathogen(s) at baseline that all are susceptible to nitrofurantoin in Japan, with that from global studies (Studies 204989 [NCT04020341] and 212390 [NCT04187144]).

Phase:

Phase 3

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Nitrofurantoin